The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells
Clinical & Experimental Metastasis, 29(2):111-22
LAMICHE C., CLARHAUT J., STRALE PO., CRESPIN S., PEDRETTI N., BERNARD FX., NAUS C., CHEN V., FOSTER L., DEFAMIE N., MESNIL M., DEBIAIS F. and CRONIER L. (2012)
CNRS, UMR6187, Institute of Cellular Physiology and Biology, University of Poitiers, Bat. B36, 1, rue G. Bonnet, BP 633, 86022, Poitiers Cedex, France.
INSERM CIC 0802, C.H.U. la Milétrie, Poitiers, France.
Bioalternatives, Gençay, France.
Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.
Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC, Canada.
Department of Rheumatology, C.H.U. la Milétrie, Poitiers, France.
For decades, cancer was associated with gap-junction defects. However, more recently it appeared that the gap junction proteins (connexins) could be re-expressed and participate to cancer cell dissemination during the late stages of tumor progression. Since primary tumors of prostate cancer (PCa) are known to be connexin deficient, it was interesting to verify whether their bone-targeted metastatic behaviour could be influenced by the re-expression of the connexin type (connexin43) which is originally present in prostate tissue and highly expressed in bone where it participates to the differentiation of osteoblastic cells.
Thus, we investigated the effect of the increased Cx43 expression, by retroviral infection, on the metastatic behaviour of two well-characterized cell lines (PC-3 and LNCaP) representing different stages of PCa progression. It appeared that Cx43 differently behaved in those cell lines and induced different phenotypes. In LNCaP, Cx43 was functional, localized at the plasma membrane and its high expression was correlated with a more aggressive phenotype both in vitro and in vivo. In particular, those Cx43-expressing LNCaP cells exhibited a high incidence of osteolytic metastases generated by bone xenografts in mice. Interestingly, LNCaP cells were also able to decrease the proliferation of cocultured osteoblastic cells. In contrast, the increased expression of Cx43 in PC-3 cells led to an unfunctional, cytoplasmic localization of the protein and was correlated with a reduction of proliferation, adhesion and invasion of the cells.
In conclusion, the localization and the functionality of Cx43 may govern the ability of PCa cells to metastasize in bones.
© 2011 Springer Science+Business Media B.V.
KEYWORDS: Connexin43; Prostate cancer; Bone metastasis; Heterocellular communication
Check out Bioalternatives’ updates and experience new testing ideas
- Bioassays, models and services
- Posts and publications